Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Mating System Homozygote x Homozygote (Female x Male) 01-OCT-09 Species laboratory mouse Generation N10F1 (12-NOV-09)
Generation DefinitionsDonating Investigator Dr. Rudolf Jaenisch, Whitehead Institute (MIT) Description
Homozygotes are viable, fertile, normal in size and do not display any behavioral abnormalities. These targeted mutant mice have widespread expression of an optimized form of reverse tetracycline-controlled transactivator (rtTA-M2) protein. This R26-M2rtTA strain may be useful for doxycycline-inducible studies which utilize rtTA/tet-O (tet-on/TRE) models.Development
A targeting vector was designed to insert an optimized form of reverse tetracycline controlled transactivator (rtTA-M2) followed by a β-globin intron and polyA signal downstream of the Gt(ROSA)26Sor promoter. This construct was electroporated into (C57BL/6 x 129S4Sv/Jae)F1-derived V6.5 embryonic stem (ES) cells. In addition, these ES cells were retargeted to insert an frt-flanked PGK-Neo was into the 3' UTR of the Col1a1 locus. Correctly targeted ES cells were selected and the frt-flanked PGK-Neo in the 3' UTR of the Col1a1 locus was replaced by injecting both a "flip-in plasmid" containing a splice acceptor-double polyA sequence and the tetracycline responsive element (TRE or tetO) upstream of the mouse Oct4 (Pou5f1) cDNA sequence, as well as a Flpe-expressing plasmid to facilitate tetO-Oct4 recombination into the 3' UTR of the Col1a1 locus. The resulting ES cells (now targeted with rtTA-M2 in the Gt(ROSA)26Sor locus and tetO-Oct4 in the Col1a1 locus) were injected into B6D2F1 tetraploid blastocysts. Chimeric mice were bred together for many generations prior to arrival at The Jackson Laboratory (as Stock No. Stock No. 006911). Upon arrival, a subset of mice were backcrossed to C57BL/6J; selecting mice harboring the mutant Gt(ROSA)26Sor allele (not harboring the Col1a1 mutant locus) for at least 5 generations to generate this congenic strain (Stock No. 006965).
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying Gt(ROSA)26Sortm1(rtTA*M2)Jae allele
014588 B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1A1tm6(tetO-MSI2)Jae/J 014602 B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm1(tetO-mCherry)Eggn/J 006911 B6;129-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm2(tetO-Pou5f1)Jae/J 016836 B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm7(tetO-HIST1H2BJ/GFP)Jae/J 011004 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm3(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011011 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm4(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011013 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm5(tetO-Pou5f1,-Klf4,-Myc)Jae/J View Strains carrying Gt(ROSA)26Sortm1(rtTA*M2)Jae (7 strains)
Strains carrying other alleles of Gt(ROSA)26Sor
002292 129-Gt(ROSA)26Sor/J 006053 129-Gt(ROSA)26Sortm1(CAG-EGFP)Luo/J 006067 129-Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo/J 006041 129-Gt(ROSA)26Sortm3(CAG-EGFP/Dsred2)Luo/J 003310 129S-Gt(ROSA)26Sortm1Sor/J 009043 129S-Gt(ROSA)26Sortm3(CAG-luc)Tyj/J 007844 129S4/SvJae-Gt(ROSA)26Sortm2(FLP*)Sor/J 003946 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J 007689 129S4/SvJaeSor-Gt(ROSA)26Sortm4(attB/attP)Sor/J 017626 B6(Cg)-Gt(ROSA)26Sortm1(CAG-GFP/Eif2c2)Zjh/J 010633 B6(Cg)-Gt(ROSA)26Sortm1(CAG-taulacZ)Bene/J 008242 B6(Cg)-Gt(ROSA)26Sortm4(Ikbkb)Rsky/J 007676 B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J 006071 B6.129-Gt(ROSA)26Sortm1(CAG-EGFP)Luo/J 007708 B6.129-Gt(ROSA)26Sortm1(HD*103Q)Xwy/J 008463 B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J 008606 B6.129-Gt(ROSA)26Sortm1Joe/J 006080 B6.129-Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo/J 006075 B6.129-Gt(ROSA)26Sortm3(CAG-EGFP/Dsred2)Luo/J 011008 B6.129P2(Cg)-Gt(ROSA)26Sortm1(tTA)Roos/J 017492 B6.129P2-Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J 009669 B6.129P2-Gt(ROSA)26Sortm1(DTA)Lky/J 008513 B6.129P2-Gt(ROSA)26Sortm1(Trpv1,ECFP)Mde/J 013586 B6.129P2-Gt(ROSA)26Sortm1Nik/J 013587 B6.129P2-Gt(ROSA)26Sortm3Nik/J 022367 B6.129S4-Gt(ROSA)26Sortm1(CAG-EGFP/Rpl10a,-birA)Wtp/J 009086 B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/RainJ 003474 B6.129S4-Gt(ROSA)26Sortm1Sor/J 012930 B6.129S4-Gt(ROSA)26Sortm2(FLP*)Sor/J 009044 B6.129S4-Gt(ROSA)26Sortm3(CAG-luc)Tyj/J 007743 B6.129S4-Gt(ROSA)26Sortm3(phiC31*)Sor/J 009673 B6.129S6(C)-Gt(ROSA)26Sortm3(HIF1A*)Kael/J 002192 B6.129S7-Gt(ROSA)26Sor/J 006148 B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J 021071 B6.Cg-Gt(ROSA)26Sortm1(CAG-PA-GFP)Rmpl/J 005670 B6.Cg-Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J 007914 B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J 007920 B6.Cg-Gt(ROSA)26Sortm2(CAG-EYFP)Hze/J 012567 B6.Cg-Gt(ROSA)26Sortm27.1(CAG-COP4*H134R/tdTomato)Hze/J 007903 B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze/J 014648 B6.Cg-Gt(ROSA)26Sortm37(H1/tetO-RNAi:Taz)Arte/ZkhuJ 021188 B6.Cg-Gt(ROSA)26Sortm40.1(CAG-aop3/EGFP)Hze/J 007906 B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J 007909 B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J 007897 B6.Cg-Tg(Gt(ROSA)26Sor-EGFP)I1Able/J 017455 B6;129-Gt(ROSA)26Sortm1(CAG-COP4*E123T*H134R,-tdTomato)Gfng/J 010527 B6;129-Gt(ROSA)26Sortm1(DTA)Mrc/J 016262 B6;129-Gt(ROSA)26Sortm1(Foxo1/GFP)Jke/J 017962 B6;129-Gt(ROSA)26Sortm1(RAC1*)Jkis/J 008883 B6;129-Gt(ROSA)26Sortm1(SNCA*A53T)Djmo/TmdJ 004847 B6;129-Gt(ROSA)26Sortm1(cre/ERT)Nat/J 008516 B6;129-Gt(ROSA)26Sortm1Joe/J 003504 B6;129-Gt(ROSA)26Sortm1Sho/J 021847 B6;129-Gt(ROSA)26Sortm1Ytchn/J 008889 B6;129-Gt(ROSA)26Sortm2(SNCA*119)Djmo/TmdJ 009253 B6;129-Gt(ROSA)26Sortm2Nat/J 004077 B6;129-Gt(ROSA)26Sortm2Sho/J 008886 B6;129-Gt(ROSA)26Sortm3(SNCA*E46K)Djmo/TmdJ 010557 B6;129-Gt(ROSA)26Sortm3(rtTA,tetO-cre/ERT)Nat/J 010523 B6;129P2-Gt(ROSA)26Sortm1(CAG-ALPP)Fawa/J 002073 B6;129S-Gt(ROSA)26Sor/J 018385 B6;129S-Gt(ROSA)26Sortm1(CAG-COX8A/Dendra2)Dcc/J 018397 B6;129S-Gt(ROSA)26Sortm1.1(CAG-COX8A/Dendra2)Dcc/J 012569 B6;129S-Gt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J 012570 B6;129S-Gt(ROSA)26Sortm34.1(CAG-Syp/tdTomato)Hze/J 012735 B6;129S-Gt(ROSA)26Sortm35.1(CAG-aop3/GFP)Hze/J 014538 B6;129S-Gt(ROSA)26Sortm38(CAG-GCaMP3)Hze/J 014539 B6;129S-Gt(ROSA)26Sortm39(CAG-hop/EYFP)Hze/J 021875 B6;129S-Gt(ROSA)26Sortm65.1(CAG-tdTomato)Hze/J 021876 B6;129S-Gt(ROSA)26Sortm66.1(CAG-tdTomato)Hze/J 003309 B6;129S4-Gt(ROSA)26Sortm1Sor/J 004598 B6;129S4-Gt(ROSA)26Sortm2Dym/J 007670 B6;129S4-Gt(ROSA)26Sortm3(phiC31*)Sor/J 016999 B6;129S6-Gt(ROSA)26Sortm1(xstpx-rtTA2S*M2)Whsu/J 007908 B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J 007905 B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J 016226 B6N.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/J 019120 BALB/c-Gt(ROSA)26Sortm10(Lmp1)Rsky/J 009670 C.129P2(B6)-Gt(ROSA)26Sortm1(DTA)Lky/J 008603 C.129P2(B6)-Gt(ROSA)26Sortm1(tTA)Roos/J 002955 C.129S7-Gt(ROSA)26Sor/J 007900 C57BL/6-Gt(ROSA)26Sortm1(HBEGF)Awai/J 008517 C57BL/6-Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/J 012637 C57BL/6-Gt(ROSA)26Sortm5(Map3k14)Rsky/J 012638 C57BL/6-Gt(ROSA)26Sortm6(Map3k14*)Rsky/J 012343 C57BL/6-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/J 012352 C57BL/6-Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/J 012361 C57BL/6-Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky/J 020458 C57BL/6N-Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky/J 005420 C;129S7 Gt(ROSA)26Sor-Bmp5cfe-se7J/GrsrJ 008040 CBy.B6-Gt(ROSA)26Sortm1(HBEGF)Awai/J 007898 CBy.Cg-Tg(Gt(ROSA)26Sor-EGFP)I1Able/J 009427 FVB.129S4(B6)-Gt(ROSA)26Sortm1Sor/J 005125 FVB.129S6(B6)-Gt(ROSA)26Sortm1(Luc)Kael/J 016977 FVB.129S6-Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/J 006206 FVB.129S6-Gt(ROSA)26Sortm2(HIF1A/luc)Kael/J 012429 FVB.Cg-Gt(ROSA)26Sortm1(CAG-lacZ,-EGFP)Glh/J 010920 FVB;129P2-Gt(ROSA)26Sortm1(birA)Mejr/J 016603 NOD.B6-Gt(ROSA)26Sortm1(HBEGF)Awai/DvsJ 013731 STOCK Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J 006331 STOCK Gt(ROSA)26Sortm1(DTA)Jpmb/J 008159 STOCK Gt(ROSA)26Sortm1(Notch1)Dam/J 005130 STOCK Gt(ROSA)26Sortm1(Smo/EYFP)Amc/J 005572 STOCK Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J 008600 STOCK Gt(ROSA)26Sortm1(tTA)Roos/J 018999 STOCK Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/J 018998 STOCK Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/J 022386 STOCK Gt(ROSA)26Sortm1.1(CAG-EGFP/Rpl10a,-birA)Wtp/J 017596 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J 017597 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J 017922 STOCK Gt(ROSA)26Sortm10(ACTB-tdTomato)Luo/J 018903 STOCK Gt(ROSA)26Sortm2(EGFP/cre)Alj/J 018906 STOCK Gt(ROSA)26Sortm3(CAG-FLPo/ERT2)Alj/J 013124 STOCK Gt(ROSA)26Sortm3(Gli3)Amc/J 007576 STOCK Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J 009674 STOCK Gt(ROSA)26Sortm4(HIF2A*)Kael/J 012266 STOCK Gt(ROSA)26Sortm5(ACTB-tTA)Luo/J 017912 STOCK Gt(ROSA)26Sortm6(ACTB-EGFP*,-tdTomato)Luo/J 013123 STOCK Gt(ROSA)26Sortm6(Gli1)Amc/J 017921 STOCK Gt(ROSA)26Sortm7(ACTB-EGFP*)Luo/J 017909 STOCK Gt(ROSA)26Sortm8(ACTB-EGFP*,-tTA2)Luo/J 007577 STOCK Tg(Gt(ROSA)26Sor-BCHE*G117H)837Loc/J 007896 STOCK Tg(Gt(ROSA)26Sor-EGFP)I1Able/J View Strains carrying other alleles of Gt(ROSA)26Sor (123 strains)
Strains carrying other alleles of rtTA
016567 129S.Cg-Tg(Hoxb7-rtTA*M2)2Cos/J 005670 B6.Cg-Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J 016997 B6.Cg-Tg(Axin2-rtTA2S*M2)7Cos/J 014098 B6.Cg-Tg(GFAP-rtTA*M2)1Rmra/J 007176 B6.Cg-Tg(Pax8-rtTA2S*M2)1Koes/J 006235 B6.Cg-Tg(SFTPC-rtTA)5Jaw/J 006232 B6.Cg-Tg(Scgb1a1-rtTA)1Jaw/J 012433 B6;C3-Tg(ACTA1-rtTA,tetO-cre)102Monk/J 010574 B6;SJL-Tg(Gh1-rtTA)4-3Jek/J 007678 B6;SJL-Tg(KRT14-rtTA)208Jek/J 010576 B6;SJL-Tg(MMTV-rtTA)4-1Jek/J 010549 B6N.Cg-Tg(Prkcd-glc-1-rtTA)2And/J 016532 B6N.FVB(Cg)-Tg(CAG-rtTA3)4288Slowe/J 006245 C.Cg-Tg(SFTPC-rtTA)5Jaw/J 006242 C.Cg-Tg(Scgb1a1-rtTA)1Jaw/J 017955 C57BL/6-Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/J 008099 FVB-Tg(KRT14-rtTA)F42Efu/J 004127 FVB-Tg(Nes-rtTA)306Rvs/J 021187 FVB-Tg(Pbsn-rtTA*M2)42Xy/J 008326 FVB-Tg(Pomc-rtTA)1Rck/J 006225 FVB.Cg-Tg(SFTPC-rtTA)5Jaw/J 006222 FVB.Cg-Tg(Scgb1a1-rtTA)1Jaw/J 008202 FVB/N-Tg(NPHS2-rtTA2*M2)1Jbk/J 006875 FVB/N-Tg(Tagln-rtTA)E1Jwst/J 004602 NOD.Cg-Tg(Ins2-rtTA)2Doi/DoiJ 005734 NOD/Lt-Tg(Ins2-rtTA)1Ach/AchJ 005572 STOCK Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J 016116 STOCK Waptm2(rtTA)Kuw/J 003273 STOCK Tg(CMV-rtTA)4Bjd/J 018156 STOCK Tg(Drd1a-rtTA)ARgmk/J 008755 STOCK Tg(Ins2-rtTA)2Efr Tg(teto-DTA)1Gfi/J 008250 STOCK Tg(Ins2-rtTA)2Efr/J 017519 STOCK Tg(KRT5-rtTA)T2D6Sgkd/J 016146 STOCK Tg(SFTPC-rtTA)2Jaw/J 016145 STOCK Tg(Scgb1a1-rtTA)2Jaw/J 005493 STOCK Tg(Tek-rtTA,TRE-lacZ)1425Tpr/J View Strains carrying other alleles of rtTA (36 strains)
Tet Expression Systems
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Neurobiology Research
Tet Expression System
tTA/rtTA Expressing Strains
Research Tools
Cancer Research
Tetop Tet System
Cardiovascular Research
Tetop Tet System
Genetics Research
Mutagenesis and Transgenesis
Mutagenesis and Transgenesis: Tetop Tet System
Neurobiology Research
Tetop Tet System
Reproductive Biology Research
Tetop Tet System
Tet Expression Systems
tTA/rtTA Expressing Strains
| Allele Symbol | Gt(ROSA)26Sortm1(rtTA*M2)Jae | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Rudolf Jaenisch | ||
| Allele Type | Targeted (knock-in) | ||
| Common Name(s) | Gt(ROSA)26Sortm1(M2rtTA)Jae; R26-M2rtTA; R26-rtTA; Rosa26-rtRA-nls; | ||
| Mutation Made By | Dr. Rudolf Jaenisch, Whitehead Institute (MIT) | ||
| Strain of Origin | (C57BL/6 x 129S4/SvJae)F1 | ||
| ES Cell Line Name | v6.5 | ||
| ES Cell Line Strain | (C57BL/6 x 129S4/SvJae)F1 | ||
| Site of Expression | Expresses an optimized rtTA protein (rtTA-M2). Inducible target gene expression is detected in liver, bone marrow, stomach, intestine, and skin, with lower levels in the heart, lungs, kidney, spleen, and thymus; no expression is detected in the brain and testes. | ||
| Expressed Gene | rtTA, reverse tetracycline-controlled transactivator, E. coli | ||
| The tetracycline repressor gene (Tetr), arose from chemically mutated Escherichia coli genome which was screened for tetracycline dependence (Gossen and Bujard, 1992). One mutant with a four amino acid residue change (rTetR) exhibited dependence on tetracycline for induction of the targeted gene and was used in the rtTA construct (Gossen et al, 1995). rTetr was fused at the C-terminus with the viral co-activator, virion protein 16 of the herpes simplex virus (VP-16). | |||
| General Note | This mutation was originally created downstream of the Col1a1tm2(tetO-Pou5f1)Jae allele in mutant ES cell line KH2 but the two mutations have subsequently been bred apart. | ||
| Molecular Note | An optimized form of reverse tetracycline controlled transactivator (rtTA-M2) was inserted downstream of the Gt(ROSA)26Sor promoter. This mutant form of rtTA termed M2 has five amino acid substitutions in the tetR moiety of tTA: S12G, E19G, A56P, D148E and H179R. This mutated form of transactivatory protein has increased doxycycline sensitivity. Mice have widespread expression of the rtTA-M2 protein. [MGI Ref ID J:98920] | ||
| Gene Symbol and Name | Gt(ROSA)26Sor, gene trap ROSA 26, Philippe Soriano | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | AV258896; Gtrgeo26; Gtrosa26; R26; ROSA26; beta geo; expressed sequence AV258896; gene trap ROSA 26; gene trap ROSA b-geo 26; | ||
Genotyping Protocols
Gt(ROSA)26Sortm1sor STD, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Hochedlinger K; Yamada Y; Beard C; Jaenisch R. 2005. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121(3):465-77. [PubMed: 15882627] [MGI Ref ID J:98920]
Gt(ROSA)26Sortm1(rtTA*M2)Jae relatedAoki H; Hara A; Era T; Kunisada T; Yamada Y. 2012. Genetic ablation of Rest leads to in vitro-specific derepression of neuronal genes during neurogenesis. Development 139(4):667-77. [PubMed: 22241837] [MGI Ref ID J:181188]
Beard C; Hochedlinger K; Plath K; Wutz A; Jaenisch R. 2006. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44(1):23-8. [PubMed: 16400644] [MGI Ref ID J:159351]
Brambrink T; Foreman R; Welstead GG; Lengner CJ; Wernig M; Suh H; Jaenisch R. 2008. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2(2):151-9. [PubMed: 18371436] [MGI Ref ID J:149805]
Brennand K; Huangfu D; Melton D. 2007. All beta Cells Contribute Equally to Islet Growth and Maintenance. PLoS Biol 5(7):e163. [PubMed: 17535113] [MGI Ref ID J:124045]
Camargo FD; Gokhale S; Johnnidis JB; Fu D; Bell GW; Jaenisch R; Brummelkamp TR. 2007. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17(23):2054-60. [PubMed: 17980593] [MGI Ref ID J:141457]
Carey BW; Markoulaki S; Beard C; Hanna J; Jaenisch R. 2010. Single-gene transgenic mouse strains for reprogramming adult somatic cells. Nat Methods 7(1):56-9. [PubMed: 20010831] [MGI Ref ID J:157298]
Dickins RA; McJunkin K; Hernando E; Premsrirut PK; Krizhanovsky V; Burgess DJ; Kim SY; Cordon-Cardo C; Zender L; Hannon GJ; Lowe SW. 2007. Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet 39(7):914-21. [PubMed: 17572676] [MGI Ref ID J:123006]
Foudi A; Hochedlinger K; Van Buren D; Schindler JW; Jaenisch R; Carey V; Hock H. 2009. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol 27(1):84-90. [PubMed: 19060879] [MGI Ref ID J:172421]
Gros J; Hu JK; Vinegoni C; Feruglio PF; Weissleder R; Tabin CJ. 2010. WNT5A/JNK and FGF/MAPK pathways regulate the cellular events shaping the vertebrate limb bud. Curr Biol 20(22):1993-2002. [PubMed: 21055947] [MGI Ref ID J:166897]
Guo S; Bai H; Megyola CM; Halene S; Krause DS; Scadden DT; Lu J. 2012. Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms. Proc Natl Acad Sci U S A 109(41):16636-41. [PubMed: 23012470] [MGI Ref ID J:190324]
He S; Kim I; Lim MS; Morrison SJ. 2011. Sox17 expression confers self-renewal potential and fetal stem cell characteristics upon adult hematopoietic progenitors. Genes Dev 25(15):1613-27. [PubMed: 21828271] [MGI Ref ID J:174416]
Heinonen KM; Vanegas JR; Brochu S; Shan J; Vainio SJ; Perreault C. 2011. Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors. Blood 118(19):5163-73. [PubMed: 21937690] [MGI Ref ID J:178890]
Hirata A; Utikal J; Yamashita S; Aoki H; Watanabe A; Yamamoto T; Okano H; Bardeesy N; Kunisada T; Ushijima T; Hara A; Jaenisch R; Hochedlinger K; Yamada Y. 2013. Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium. Development 140(1):66-75. [PubMed: 23222438] [MGI Ref ID J:191050]
Holl D; Kuckenberg P; Woynecki T; Egert A; Becker A; Huss S; Stabenow D; Zimmer A; Knolle P; Tolba R; Fischer HP; Schorle H. 2011. Transgenic Overexpression of Tcfap2c/AP-2gamma Results in Liver Failure and Intestinal Dysplasia. PLoS One 6(7):e22034. [PubMed: 21779369] [MGI Ref ID J:174049]
Jaako P; Flygare J; Olsson K; Quere R; Ehinger M; Henson A; Ellis S; Schambach A; Baum C; Richter J; Larsson J; Bryder D; Karlsson S. 2011. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 118(23):6087-96. [PubMed: 21989989] [MGI Ref ID J:179085]
Jansson L; Larsson J. 2012. Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1. PLoS One 7(2):e32013. [PubMed: 22363786] [MGI Ref ID J:185310]
Jarde T; Evans RJ; McQuillan KL; Parry L; Feng GJ; Alvares B; Clarke AR; Dale TC. 2013. In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-ODeltaN89beta-catenin system. Oncogene 32(7):883-93. [PubMed: 22469981] [MGI Ref ID J:193365]
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Frohling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ. 2010. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med 16(8):903-8. [PubMed: 20616797] [MGI Ref ID J:163322]
Laplante M; Horvat S; Festuccia WT; Birsoy K; Prevorsek Z; Efeyan A; Sabatini DM. 2012. DEPTOR Cell-Autonomously Promotes Adipogenesis, and Its Expression Is Associated with Obesity. Cell Metab 16(2):202-12. [PubMed: 22883231] [MGI Ref ID J:187378]
Linhart HG; Lin H; Yamada Y; Moran E; Steine EJ; Gokhale S; Lo G; Cantu E; Ehrich M; He T; Meissner A; Jaenisch R. 2007. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21(23):3110-22. [PubMed: 18056424] [MGI Ref ID J:127808]
Lopez ME; Klein AD; Dimbil UJ; Scott MP. 2011. Anatomically defined neuron-based rescue of neurodegenerative niemann-pick type C disorder. J Neurosci 31(12):4367-78. [PubMed: 21430138] [MGI Ref ID J:170312]
Lopez ME; Klein AD; Hong J; Dimbil UJ; Scott MP. 2012. Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. Hum Mol Genet 21(13):2946-60. [PubMed: 22493001] [MGI Ref ID J:184610]
Magnusson M; Brun AC; Miyake N; Larsson J; Ehinger M; Bjornsson JM; Wutz A; Sigvardsson M; Karlsson S. 2007. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 109(9):3687-96. [PubMed: 17234739] [MGI Ref ID J:145322]
Markoulaki S; Hanna J; Beard C; Carey BW; Cheng AW; Lengner CJ; Dausman JA; Fu D; Gao Q; Wu S; Cassady JP; Jaenisch R. 2009. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27(2):169-71. [PubMed: 19151700] [MGI Ref ID J:158492]
McJunkin K; Mazurek A; Premsrirut PK; Zuber J; Dow LE; Simon J; Stillman B; Lowe SW. 2011. Reversible suppression of an essential gene in adult mice using transgenic RNA interference. Proc Natl Acad Sci U S A 108(17):7113-8. [PubMed: 21482754] [MGI Ref ID J:171348]
Paliwal P; Conboy IM. 2011. Inhibitors of tyrosine phosphatases and apoptosis reprogram lineage-marked differentiated muscle to myogenic progenitor cells. Chem Biol 18(9):1153-66. [PubMed: 21944754] [MGI Ref ID J:190199]
Petrelli A; Carvello M; Vergani A; Lee KM; Tezza S; Du M; Kleffel S; Chengwen L; Mfarrej BG; Hwu P; Secchi A; Leonard WJ; Young D; Sayegh MH; Markmann JF; Zajac AJ; Fiorina P. 2011. IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes 60(12):3223-34. [PubMed: 22013017] [MGI Ref ID J:191409]
Premsrirut PK; Dow LE; Kim SY; Camiolo M; Malone CD; Miething C; Scuoppo C; Zuber J; Dickins RA; Kogan SC; Shroyer KR; Sordella R; Hannon GJ; Lowe SW. 2011. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145(1):145-58. [PubMed: 21458673] [MGI Ref ID J:171191]
Quere R; Andradottir S; Brun AC; Zubarev RA; Karlsson G; Olsson K; Magnusson M; Cammenga J; Karlsson S. 2011. High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia 25(3):515-26. [PubMed: 21116281] [MGI Ref ID J:170242]
Sehrawat S; Koenig PA; Kirak O; Schlieker C; Fankhauser M; Ploegh HL. 2013. A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation. Blood 121(7):1145-56. [PubMed: 23243279] [MGI Ref ID J:194608]
Stadtfeld M; Maherali N; Borkent M; Hochedlinger K. 2010. A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat Methods 7(1):53-5. [PubMed: 20010832] [MGI Ref ID J:159350]
Tumaneng K; Schlegelmilch K; Russell RC; Yimlamai D; Basnet H; Mahadevan N; Fitamant J; Bardeesy N; Camargo FD; Guan KL. 2012. YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 14(12):1322-9. [PubMed: 23143395] [MGI Ref ID J:195253]
Wan M; Gu H; Wang J; Huang H; Zhao J; Kaundal RK; Yu M; Kushwaha R; Chaiyachati BH; Deerhake E; Chi T. 2013. Inducible mouse models illuminate parameters influencing epigenetic inheritance. Development 140(4):843-52. [PubMed: 23325759] [MGI Ref ID J:194064]
Wan M; Kaundal R; Huang H; Zhao J; Yang X; Chaiyachati BH; Li S; Chi T. 2013. A general approach for controlling transcription and probing epigenetic mechanisms: application to the CD4 locus. J Immunol 190(2):737-47. [PubMed: 23293358] [MGI Ref ID J:191711]
Watanabe S; Hirai H; Asakura Y; Tastad C; Verma M; Keller C; Dutton JR; Asakura A. 2011. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 29(3):505-16. [PubMed: 21425413] [MGI Ref ID J:175957]
Wesemann DR; Portuguese AJ; Magee JM; Gallagher MP; Zhou X; Panchakshari RA; Alt FW. 2012. Reprogramming IgH isotype-switched B cells to functional-grade induced pluripotent stem cells. Proc Natl Acad Sci U S A 109(34):13745-50. [PubMed: 22869756] [MGI Ref ID J:188595]
Yamada K; Ohno T; Aoki H; Semi K; Watanabe A; Moritake H; Shiozawa S; Kunisada T; Kobayashi Y; Toguchida J; Shimizu K; Hara A; Yamada Y. 2013. EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice. J Clin Invest :. [PubMed: 23281395] [MGI Ref ID J:194505]
Yamada Y; Aoki H; Kunisada T; Hara A. 2010. Rest promotes the early differentiation of mouse ESCs but is not required for their maintenance. Cell Stem Cell 6(1):10-5. [PubMed: 20085738] [MGI Ref ID J:157076]
Zhu H; Shah S; Shyh-Chang N; Shinoda G; Einhorn WS; Viswanathan SR; Takeuchi A; Grasemann C; Rinn JL; Lopez MF; Hirschhorn JN; Palmert MR; Daley GQ. 2010. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat Genet 42(7):626-30. [PubMed: 20512147] [MGI Ref ID J:166568]
Zhu H; Shyh-Chang N; Segre AV; Shinoda G; Shah SP; Einhorn WS; Takeuchi A; Engreitz JM; Hagan JP; Kharas MG; Urbach A; Thornton JE; Triboulet R; Gregory RI; Altshuler D; Daley GQ. 2011. The Lin28/let-7 Axis Regulates Glucose Metabolism. Cell 147(1):81-94. [PubMed: 21962509] [MGI Ref ID J:177113]
Zong Y; Huang J; Sankarasharma D; Morikawa T; Fukayama M; Epstein JI; Chada KK; Witte ON. 2012. Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling. Proc Natl Acad Sci U S A 109(50):E3395-404. [PubMed: 23184966] [MGI Ref ID J:193135]
van Amerongen R; Fuerer C; Mizutani M; Nusse R. 2012. Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development. Dev Biol 369(1):101-14. [PubMed: 22771246] [MGI Ref ID J:187621]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, homozygous mice may be bred together. Mating System Homozygote x Homozygote (Female x Male) 01-OCT-09 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $177.00 Female or Male Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae
Price per Pair (US dollars $) Pair Genotype $354.00 Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae x Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $230.10 Female or Male Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae
Price per Pair (US dollars $) Pair Genotype $460.20 Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae x Homozygous for Gt(ROSA)26Sortm1(rtTA*M2)Jae Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
- Use of MICE by companies or for-profit entities requires a license.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.